Interview with KEFEA President, Kyriakos Mikellis, published in Politis newspaper Read the interview here 20150222KEFEA President interview
Join initiatives by CIPA – KEFEA The potential to attract investments in the pharmaceutical industry and develop joint initiatives to improve the investment climate were discussed during a meeting between the Cyprus Investment Promotion Agency (CIPA) and the Cyprus...
He will discuss the NHS with the Finance and Health Ministers The implementation of the National Health System (NHS), as well as Cypriot patients’ access to innovative medicines, will be discussed during separate meetings between the Director General of the European...
Pharmaceutical companies will disclose expenses covered for healthcare professionals with the aim of boosting transparency The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) takes press coverage on the World Health Organisation’s (WHO)...
NHS and patients’ access to innovative medicines of top priority Kyriakos Mikellis, Cyprus Business Manger at Pfizer, has been elected as the new President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) for the next two years....
Pharmaceutical companies will disclose transfers of value to healthcare professionals, as part of a Europe-level initiative to apply a stricter self-regulatory framework in the sector and increase transparency. Details on the provisions of the revised “Code of Conduct...
KEFEA meeting with the Troika The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) greatly concerned over media reports which claim that only one medicine will be available for every disease following the implementation of the National...
Constant references to “expensive” medicines and wrongful comparisons between the private sector prices in Cyprus and prices of other countries with comprehensive health systems, paint a distorted picture of medicine prices in Cyprus. The Cyprus Association of...
The implementation of a modern and sustainable healthcare system, which will guarantee the provision of top-level health services and at the same time enable equitable access to innovative medicines for all patients, was the subject of discussion in a meeting between...
Stricter provisions on the promotion of prescription medicines to healthcare professionals are among others points included in the revised Code of Practice by the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA). The new Code, which has...
Joanna Kozakou, Operations Manager of Sanofi, has assumed the position of President of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA), following the departure of Daan Gijbels from Cyprus who will undertake a new position as Area...
The Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA) welcomes the decision to operate the Medical School at the University of Cyprus come September and is pleased that the various obstacles have been overcome. KEFEA also congratulates...
